Skip to content
Medical Health Aged Care

GPs praise Victorian budget’s ‘lifesaving’ meningococcal B and ADHD reforms

Royal Australian College of GPs 2 mins read

Victorian GPs have praised commitments to protect young people from deadly meningitis and give more patients access to ADHD care from their GP in the state’s 2026–27 budget.

The Royal Australian College of GPs (RACGP) has long said free vaccination against the meningococcal B strain for babies and teens will save lives, and advocated for free vaccines for all infants and children aged under two years old and healthy adolescents aged 15–19, as recommended by the Australian Immunisation Handbook.

While the vaccine for meningococcal A, C, W, and Y strains is free under the National Immunisation Program for all children and young people, the vaccine against the B strain is not provided for all children and generally requires an out-of-pocket payment of $110–150 per dose.

“Meningitis isn’t predictable, but it is preventable. Free MenB vaccinations will be lifesaving,” RACGP Victoria Chair Dr Anita Muñoz said.

“We’re pleased the Victorian Government has listened to GPs and implemented public health recommendations.

“But no one has been more instrumental in making this change than Norliah Syer-Peterson, who has campaigned for this since her 16-year-old son, Levi Syer, died due to a meningococcal B infection last September.

“No one should have to experience what Norliah and her family have. She made it clear how fast, brutal, and unforgiving meningococcal B is, and the Government has responded.

“It’s appropriate for an essential vaccine like MenB to be part of a national approach, but this should be implemented as soon as possible so all babies and teens are immunised, including catch-up MenB vaccinations for those who should have received a vaccine already.”

Four cases of meningococcal disease have been reported in Victoria already this year, and 18 in the past 12 months.

Reforms to allow specialist GPs with appropriate training to safely diagnose, treat and prescribe medication for ADHD will be introduced by September, and Dr Muñoz emphasised the readiness of Victorian GPs to support more accessible and affordable care.

The Victorian Government has committed an initial $750,000 to support accredited training for an initial group of 150 GPs to accurately assess and provide evidence-based diagnosis for ADHD.

“For too long, too many patients have been left without appropriate care by our health system,” Dr Muñoz said.

“Your postcode currently determines your access to ADHD care. Patients in the most disadvantaged areas shouldn’t have access common ADHD medications at less than half the rate of those in our most advantaged areas.

“This has real effects. Patients with ADHD die almost seven years sooner. ADHD is around five times more prevalent among youth prisoners, and 10 times higher among adults. People with ADHD are significantly more likely to develop a substance use disorder.

“Ensuring all patients who need it can access timely, accurate, and affordable ADHD assessments and ongoing care from their GP will change lives, and likely save lives too.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Dominique Yohanes
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 15/07/2026
  • 16:17
Sinovac Biotech Ltd.

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate…

  • Medical Health Aged Care
  • 15/07/2026
  • 16:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG leadership transition after 15 years of transformative growth

FOR IMMEDIATE RELEASE 15 July 2026 The Australia New Zealand Gynaecological Oncology Group (ANZGOG) today announced its planned leadership transition, with Chief Executive Officer Alison Evans stepping down after close to 15 years leading theorganisationand the appointment of new CEO Caitlin Francis. This transition marks the next chapter forANZGOG, Australia and New Zealand's peakgynaecologicalcancer researchorganisation. Backed by a strong leadership team, dedicated staff and enduring partnerships across research institutes, government,philanthropyand industry, ANZGOG has grown from 423 members to now more than 1,650. During this period, theorganisationhasmore thandoubled its portfolio of clinical trials and delivered internationallyrecognisedresearch that is advancing the diagnosis,treatmentand…

  • Medical Health Aged Care
  • 15/07/2026
  • 13:28
Palliative Care Australia

Sectors welcome Senate call to remove limits on end-of-life care at home

Older people with life-limiting illness should be able to receive the care they need at home, without their support being constrained by fixed funding and time restrictions, Ageing Australia and Palliative Care Australia (PCA) said today. The two peak bodies have welcomed a Senate Community Affairs References Committee recommendation to abolish the funding and time restrictions placed on the Support at Home End-of-Life Pathway and develop a flexible, clinically guided, needs-based model for end-of-life care at home. Ageing Australia and PCA said the recommendation recognises that care at the end of life should be shaped around a person’s needs, not…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.